ABOUT US

Affacare Medical (Beijing) Co., Ltd.

Dedicated to building the company into a surgical instrument platform company



Beijing Affacare Medical Co., Ltd., founded in 2012, was the first high-tech enterprise in China to achieve the domestic production of surgical ultrasonic scalpels. The company pioneered the "One Patient, One Scalpel" usage concept, driving the industry's shift toward single-use ultrasonic scalpels.

Since its establishment, Affacare has focused on the R&D, manufacturing, and sales of minimally invasive surgical products, including ultrasonic scalpels and ultrasonic pneumatic lithotripsy systems. The company is dedicated to reducing healthcare costs through technological innovation, making high-quality surgical instruments more accessible.

With over 70 patents, Affacare’s self-developed ultrasonic surgical system meets the advanced standards of international counterparts and has been selected for the Excellent Domestic Medical Device Product Catalog. The company holds certifications including GMP, ISO 13485, and MDSAP, along with regulatory approvals from NMPA, CE, and others. Its products serve more than 1,800 medical institutions across China and have been used in over one million surgical procedures.

Looking ahead, Affacare remains committed to its mission: “Dedicated to Every Surgery.” The company plans to expand its product portfolio to include energy platforms, endoscopic consumables, and tumor ablation solutions, while continuing to deepen its expertise in minimally invasive surgery and accelerate global expansion—striving to become a trusted surgical partner for surgeons worldwide.

To take care of
13 +

Clinical surgical application

300 +

Existing employees

70 +

National patent

2200 +

Serve medical institutions

2 + Million

Clinical surgical application

20 +

Global Business Expansion Countries

Corporate culture



In the future, Affacare will take "serving every surgery with dedication" as its mission, expand its product lines—including energy platforms, endoscopic consumables, and tumor ablation—and continue to deepen its expertise in minimally invasive surgery. We will accelerate our global expansion and become a trusted surgical partner for surgeons.

Responsibility

Advocate for and practice "one person, one knife, one discard."

It is the company’s responsibility to society.

Unity

Employees work together in unity.

Joint Struggle

Persistence

We are relentlessly striving to build the company into an outstanding platform enterprise for surgical medical devices.

Achievement

Fully leverage the talents and wisdom of employees.

Build the company's brand

Honorary Qualifications



The company currently holds over 70 patents. Its independently developed ultrasonic surgical system has reached an advanced international standard comparable to similar products and has been included in the Catalog of Outstanding Domestically Produced Medical Devices. The products have obtained GMP, ISO 13485, and MDSAP certifications and have been approved by NMPA, CE, and other regulatory authorities. The company serves more than 1,800 medical institutions nationwide, with clinical applications exceeding 1 million surgical procedures.

Certificate of Membership in the Beijing Anhe Intellectual Property Alliance Group
Beijing Municipality “Specialized, Fine, and New” SME Certificate
Beijing Municipality Certificate for Foreign-Invested R&D Centers
High-tech Enterprise Certificate
Zhongguancun High-Tech Enterprise Certificate

Development History



Founded in 2012, the company is one of China’s earliest high-tech enterprises to achieve domestic production of surgical ultrasonic scalpels. It was also the first to introduce the “one person, one blade, one-time disposal” usage concept, thereby driving the industry’s shift toward single-use ultrasonic scalpels.

2023

2021

2020

2019

2018

2017

2016

2012


2023

Year

July Launch of the 5mm disposable ultrasonic surgical scalpel.

2021

Year

May Affacare receives the "Specialized, Sophisticated, Distinctive, and Innovative" (SRDI) SME certification for 2021 from the Beijing Municipal Bureau of Economy and Information Technology.

August CBC Group announces its investment in Affacare Medical, a leading ultrasonic scalpel company.

2020

Year

November Addition of  AH-631-O ,  AH-631-T , AH-631-L-C  and  AH-631-S-C  scalpel models to the ultrasonic surgical system.

December Launch of the AH-2000 Micro Electrosurgical Unit.

2019

Year

Affacare announces the launch of its Ultrasonic & Pneumatic Lithotripsy System.

2018

Year

December Addition of AH-636-B handpiece model to the ultrasonic surgical system.

2017

Year

January Addition of AH-631-S scalpel model to the ultrasonic surgical system.

June The Chinese Medical Association announces the launch of its "National County-Level Hospital Talent Training Program".

2016

Year

March Launch of the first AH-600 Ultrasonic Surgical System.

October Affacare announces the launch of its Percutaneous Nephrostomy Kit.

2012

Year

Since its founding, Affacare has pioneered the "One Patient, One Scalpel" approach in China's surgical industry.

To take care of

Product Inquiry



We provide you with high-quality products and services.

Submit